Patients are searching for this trial right now

This page is already ranking on Google. Activate it to start receiving pre-qualified patient leads directly in your inbox.

14-day free trial · $44/mo after · Cancel anytime · Money-back guarantee

NCT07089953 · M.D. Anderson Cancer Center

Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

What this study is about

To learn about how patients view a doctor's compassion, communication skills, and professionalism based on whether the doctor uses the Electronic Health Record (EHR) during a visit with a patient.

View original scientific description

To learn about how patients view a doctor's compassion, communication skills, and professionalism based on whether the doctor uses the Electronic Health Record (EHR) during a visit with a patient.

Interventions

OTHER

Questionnaire

Complete 3 questionnaires about your emotions and your trust in doctors.

OTHER

Video

Four (4) videos, each 4 minutes long, have been made for use in this study.

Primary outcome measures

Questionnaires/Videos

Time frame: Through study completion; an average of 1 year

Who can participate

This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.

Inclusion criteria

  • Eligibility Criteria
  • Participants with a diagnosis of cancer either early disease or advanced cancer defined as locally advanced, recurrent, or metastatic disease.
  • Outparticipants (either new referrals or follow-ups) seen in the Supportive Care Clinic.
  • Age \>/= 18 years old.
  • Able to read, write, and speak English.
  • Participants with normal cognitive status (Memorial Delirium Assessment Scale (MDAS) \</= 6/30) who can understand the nature and purpose of the study and have the ability to complete the consent process. Exclusion Criteria
  • Participants who are experiencing severe symptom distress, including severe emotional distress, which may interfere with study participation. This will be measured by the Edmonton Symptom Assessment Scale (ESAS). Eligibility of participants with ESAS score \>/= 7 on any item will be determined by the principal investigator and/or attending physician who is caring for the patient during that visit.
  • Participants with cognitive dysfunction (Memorial Delirium Assessment Scale (MDAS) \>/= 7/30 will be excluded from the study.

Exclusion criteria

  • Participants who are experiencing severe symptom distress, including severe emotional distress, which may interfere with study participation. This will be measured by the Edmonton Symptom Assessment Scale (ESAS). Eligibility of participants with ESAS score \>/= 7 on any item will be determined by the principal investigator and/or attending physician who is caring for the patient during that visit.
  • Participants with cognitive dysfunction (Memorial Delirium Assessment Scale (MDAS) \>/= 7/30 will be excluded from the study.

Where

  • Houston, Texas

Related conditions & keywords

Communication SkillsProfessionalismRandomized Controlled TrialPerception

Frequently asked questions

What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Data: ClinicalTrials.gov · synced Aug 6, 2026 · Source of record for eligibility and locations

📊
1 of 88 participants interested
1% interest

See if this study fits

A short prescreen based on this study's listed criteria. A coordinator confirms eligibility — this is not a medical assessment.

Preparing your pre-screening questions…

Study locations

Choose your preferred location, or select flexible during enrollment.

RECRUITING

Houston

Texas

Location available

Express your interest

Share your contact details and a study coordinator can follow up about screening.

Secure & Confidential

Your information is protected and will only be shared with the research team.

What participation can include

  • Study-related care provided by the research team
  • Close monitoring by medical professionals
  • Possible compensation for time and travel*
  • The option to withdraw at any time
  • Contributing to medical research that may help future patients

*Compensation varies by study. Confirm details with coordinator.

Typical next steps

  1. 1.Submit this form
  2. 2.Phone screening
  3. 3.In-person assessment if eligible
  4. 4.Begin participation

Find More Multiple Myeloma Trials by City

Browse all multiple myeloma clinical trials in these cities — not just this study.

Looking for Communication Skills Treatment in Houston?

Join others in Texas exploring innovative treatment options through clinical research

Communication Skills Treatment Options in Houston, Texas

If you're searching for Communication Skills treatment in Houston, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Houston and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Communication Skills. All study-related care is provided at no cost to participants.

Local Sites
1 locations in Texas
Now Enrolling
Up to 88 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Communication Skills?

Potential Benefits

  • Access to new treatment approaches before public availability
  • Close monitoring by experienced medical professionals
  • Study-related care provided at no cost
  • Contribute to medical research for Communication Skills

What to Expect

  • Initial screening to determine eligibility
  • Regular check-ups and monitoring visits
  • Possible compensation for time and travel
  • You can withdraw at any time

Frequently Asked Questions About This Communication Skills Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT07089953. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.